|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00673 CHINA HEALTH
Nominal 
0.370 -0.330 (-47.143%) | 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | |
| Turnover | 18,680 | -33.918% | 28,268 | 32,324 | 42,022 | 33,414 |
| Cost of Sales | (16,687) | -28.175% | (23,233) | (23,049) | (32,304) | (24,130) |
| Gross Profit | 1,993 | -60.417% | 5,035 | 9,275 | 9,718 | 9,284 |
| 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (864) | (17,201) | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | (1) | 0 | 0 | |
| Profit / (Loss) before Taxation | (17,607) | 6.806% | (16,485) | (27,497) | (4,702) | (2,539) | |
| Taxation | (17) | -69.643% | (56) | (25) | (82) | (438) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 237 | -83.997% | 1,481 | (89) | (423) | (1,022) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (17,387) | 15.452% | (15,060) | (27,611) | (5,207) | (3,999) | |
| 2024/09 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/09 HKD(K$) | 2022/09 HKD(K$) | 2021/09 HKD(K$) | 2020/09 HKD(K$) | |
| Net Finance Costs / (Income) | (451) | 355.556% | (99) | 795 | 162 | (3,175) |
| Depreciation & Amortisation | 944 | -45.747% | 1,740 | 2,599 | 2,504 | 2,026 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/09 - Interim | %Chg (Compare to Interim) | 2023/09 | 2022/09 | 2021/09 | 2020/09 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/09 - Interim | %Chg (Compare to Interim) | 2023/09 | 2022/09 | 2021/09 | 2020/09 | |
| EPS (cts) | -3.590 | 12.539% | -3.190 | -6.610 | -1.260 | -1.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.089 | -- | 0.157 | 0.131 | 0.199 | 0.230831 |
| Remarks: | Real time quote last updated: 27/12/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -17,387,000 |
| %Change | 15.452% |
| EPS / (LPS) | HKD -0.036 |
| NBV Per Share ($) | HKD 0.089 |